Skip to main navigation Skip to search Skip to main content

Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II Trials

  • Bas D. Koster
  • , Mari F. C. M. van den Hout
  • , Berbel J. R. Sluijter
  • , Barbara G. Molenkamp
  • , Ronald J. C. L. M. Vuylsteke
  • , Arnold Baars
  • , Paul A. M. van Leeuwen
  • , Rik J. Scheper
  • , M. Petrousjka van den Tol
  • , Alfons J. M. van den Eertwegh
  • , Tanja D. de Gruijl*
    • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II Trials'. Together they form a unique fingerprint.
Sort by

Keyphrases

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology